Home » Topics » Regulatory » Patents

Patents
RSS

HIV integrase inhibitors under study at CNRS

Nov. 25, 1998

AxyS describes new serine protease inhibitors for inflammatory disorders

Nov. 25, 1998

Lilly's new glutamate receptor antagonists for pain

Nov. 25, 1998

Herpesvirus protease inhibitors developed at SmithKline Beecham

Nov. 25, 1998

Central alpha2-adrenoceptor antagonists claimed by Janssen for depression, Parkinson's disease

Nov. 25, 1998

Substituted heteroaromatic 5-ht1f agonists in development at Lilly as antimigraine agents

Nov. 24, 1998

Novel CRF1-specific ligands claimed by Neurogen

Nov. 24, 1998

Heterocyclic hypoglycemic agents from SB for diabetes and related disorders

Nov. 24, 1998

Pyridazine and phthalazine derivatives from SmithKline Beecham for CNS, neurological disorders

Nov. 24, 1998

Lamivudine prodrugs targeting macrophages reported by European investigators

Nov. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.